US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Tri-Mix

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1765-2015
Class II · Moderate risk Terminated

Tri-Mix

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1764-2015
Class II · Moderate risk Terminated

Tri-Mix

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1763-2015
Class II · Moderate risk Terminated

Tri-Mix

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1762-2015
Class II · Moderate risk Terminated

Tri-Mix

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1761-2015
Class II · Moderate risk Terminated

Testosterone Tri-Blend 200 mg/ml

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1760-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 40 mg/ml Injectable

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1759-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 250 mg/ml Injection

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1758-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 40 mg/ml

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1757-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 220 mg/ml Injection

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1756-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 250 mg/ml Injection

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1755-2015
Class II · Moderate risk Terminated

Testosterone Cypionate 50 mg/ml Injection

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1754-2015
Class II · Moderate risk Terminated

Testosterone 87.5 mg Sterile Pellet

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1751-2015
Class II · Moderate risk Terminated

Testosterone 70 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1750-2015
Class II · Moderate risk Terminated

Testosterone 60 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1749-2015
Class II · Moderate risk Terminated

Testosterone 37.5 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1748-2015
Class II · Moderate risk Terminated

Testosterone 30 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1747-2015
Class II · Moderate risk Terminated

Testosterone 25 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1746-2015
Class II · Moderate risk Terminated

Testosterone 200 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1745-2015
Class II · Moderate risk Terminated

Testosterone 20 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1744-2015
Class II · Moderate risk Terminated

Testosterone 12.5 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1743-2015
Class II · Moderate risk Terminated

Testosterone 100 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1742-2015
Class II · Moderate risk Terminated

Testosterone 18 mg

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1741-2015